These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8167441)

  • 1. Effect of oral therapy with monoisoamyl meso-2,3-dimercaptosuccinate on 203Hg retention in rats.
    Kostial K; Blanusa M; Piasek M; Jones MM; Singh PK
    Bull Environ Contam Toxicol; 1994 Apr; 52(4):492-7. PubMed ID: 8167441
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoisoamyl meso-2,3-dimercaptosuccinate as a delayed treatment for mercury removal in rats.
    Kostial K; Kargacin B; Blanusa M; Piasek M; Jones MM; Singh PK
    Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):309-11. PubMed ID: 7843123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of Mi-ADMS to DMSA as parenteral treatment for decreasing mercury (203Hg) body burden in rats.
    Kostial K; Blanusa M; Piasek M; Simonović I; Jones MM; Singh PK
    Arh Hig Rada Toksikol; 1993 Sep; 44(3):217-22. PubMed ID: 8311694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoisoamyl and mono-n-hexyl meso-2,3-dimercaptosuccinate in mobilizing 203Hg retention in relation to age of rats and route of administration.
    Kostial K; Blanusa M; Piasek M; Prester L; Jones MM; Singh PK
    J Appl Toxicol; 1995; 15(3):201-6. PubMed ID: 7560740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged oral treatment with two monoesters of meso-2,3-dimercaptosuccinic acid for depleting inorganic mercury retention in suckling rats.
    Kostial K; Blanusa M; Piasek M; Jones MM; Singh PK
    Pharmacol Toxicol; 1995 Sep; 77(3):216-8. PubMed ID: 8884886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined oral treatment with racemic and meso-2,3-dimercaptosuccinic acid for removal of mercury in rats.
    Kostial K; Restek-Samarzija N; Blanusa M; Piasek M; Jones MM; Singh PK
    Pharmacol Toxicol; 1997 Nov; 81(5):242-4. PubMed ID: 9396091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing 203Hg retention by intraperitoneal treatment with monoalkyl esters of meso-2,3-dimercaptosuccinic acid in rats.
    Kostial K; Blanusa M; Simonović I; Jones MM; Singh PK
    J Appl Toxicol; 1993; 13(5):321-5. PubMed ID: 8258628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related efficiency of mono-n-hexyl meso-2,3-dimercaptosuccinate in decreasing 203Hg retention in rats.
    Kostial K; Blanusa M; Prester L; Jones MM; Singh PK
    Pharmacol Toxicol; 1995 Jul; 77(1):79-80. PubMed ID: 8532616
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of the protective activity of monisoamyl meso-2,3-dimercaptosuccinate against methylmercury-induced maternal and embryo/fetal toxicity in mice.
    Bellés M; Sánchez DJ; Gómez M; Domingo JL; Jones MM; Singh PK
    Toxicology; 1996 Jan; 106(1-3):93-7. PubMed ID: 8571406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of in vivo cadmium-mobilizing agents: synthesis and properties of monobenzyl meso-2,3-dimercaptosuccinate.
    Jones MM; Singh PK; Basinger MA; Gale GR; Smith AB; Harris WR
    Chem Res Toxicol; 1994; 7(3):367-73. PubMed ID: 8075368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of sodium dimercaptosuccinate for decrease of radiation burden of renal scintigraphy by chlormerodrin-203Hg.
    Vanlić-Razumenić NM; Paunković ND; Drasković RJ; Konstantinovska DD; Maksin TJ
    Int J Appl Radiat Isot; 1979 Aug; 30(8):473-80. PubMed ID: 225279
    [No Abstract]   [Full Text] [Related]  

  • 12. Haematological, hepatic and renal alterations after repeated oral or intraperitoneal administration of monoisoamyl DMSA. I. Changes in male rats.
    Mehta A; Kannan GM; Dube SN; Pant BP; Pant SC; Flora SJ
    J Appl Toxicol; 2002; 22(6):359-69. PubMed ID: 12424740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats.
    Bhadauria S; Flora SJ
    Cell Biol Toxicol; 2007 Mar; 23(2):91-104. PubMed ID: 17086449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of dimercaptosuccinic acid per os on distribution and excretion of 210Pb and 203Hg in mice].
    Liang YY; Zhang JS; Tao ZQ; Yan XM; Xu XH; Chen ZJ
    Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):379-82. PubMed ID: 7801787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing the efficiency of chelation therapy.
    Kostial K; Kargacin B; Arezina R; Landeka M; Simonović I
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(4):337-50. PubMed ID: 1804865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chelation therapy in intoxications with mercury, lead and copper.
    Cao Y; Skaug MA; Andersen O; Aaseth J
    J Trace Elem Med Biol; 2015; 31():188-92. PubMed ID: 24894443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoisoamyl 2, 3-dimercaptosuccinic acid (MiADMSA) demonstrates higher efficacy by oral route in reversing arsenic toxicity: a pharmacokinetic approach.
    Flora SJ; Bhadauria S; Pachauri V; Yadav A
    Basic Clin Pharmacol Toxicol; 2012 May; 110(5):449-59. PubMed ID: 22117535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of monoisoamyl meso-2,3-dimercaptosuccinate on the pathology of acute cadmium intoxication.
    Xu C; Holscher MA; Jones MM; Singh PK
    J Toxicol Environ Health; 1995 Jul; 45(3):261-77. PubMed ID: 7609002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in brain biogenic amines and haem biosynthesis and their response to combined administration of succimers and Centella asiatica in lead poisoned rats.
    Saxena G; Flora SJ
    J Pharm Pharmacol; 2006 Apr; 58(4):547-59. PubMed ID: 16597373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Environ Health Perspect; 2001 Jun; 109(6):613-9. PubMed ID: 11445516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.